Recombinant adenoviruses for gene therapy in cancers
US5837531A · kind A · utility
10Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 1996 |
| Grant date | Nov 17, 1998 |
| Priority date | — |
| Expiry date | May 13, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns recombinant viruses comprising a heterologous DNA sequence under the control of expression signals specifically active in tumour cells, and their preparation and use in the treatment and prevention of cancers
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.